Status:
RECRUITING
Evaluation of Erythropoietin on Alveolar Ridge Preservation
Lead Sponsor:
Ain Shams University
Conditions:
Alveolar Bone Loss
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
regenerative materials would help in decreasing post-extraction resorption in sites indicated for placement of a conventional bridge or prosthetically driven implant. Erythropoietin (EPO) is a growth ...
Detailed Description
II. Aim of the study: To assess the efficiency of Erythropoietin in alveolar ridge preservation. 1\. Objectives: Primary objective: Dimensional changes of the ridge clinically and radiographically...
Eligibility Criteria
Inclusion
- Age range (18-40).
- Hopeless teeth indicated for extraction such as root fractures, caries, internal root resorption, external root resorption, endodontic failures.
- Systemically free patients using Cornell Medical Index-Health Questionnaire \[36\].
- Patients diagnosed with intact surrounding alveolar bone (socket type I) \[37\].
- Maxillary anterior teeth and/or premolars indicated for extraction.
- Enough zone of keratinized tissue (≥2 mm).
Exclusion
- Smokers
- Occlusal trauma at the site of the graft
- Pregnancy and lactation
- Bad compliance with the plaque control instructions following initial therapy.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06513039
Start Date
January 1 2024
End Date
January 1 2025
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry Ain Shams University
Cairo, Egypt, 11361